ARS Pharmaceuticals, Inc. (SPRY) Net Income by Year
ARS Pharmaceuticals, Inc. reported a net loss of $171.3M in fiscal year 2025. This represents a decrease of 2241.8% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $215.4M net loss. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters ARS Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SPRY Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
SPRY Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More ARS Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was ARS Pharmaceuticals, Inc.'s net income in fiscal year 2025?
ARS Pharmaceuticals, Inc. reported a net loss of $171.3M in fiscal year 2025.
How fast is ARS Pharmaceuticals, Inc.'s net income growing?
ARS Pharmaceuticals, Inc. (SPRY) net income fell by 2241.8% year over year, from $8.0M to -$171.3M in fiscal year 2025.
What is ARS Pharmaceuticals, Inc.'s net income over the last twelve months?
ARS Pharmaceuticals, Inc. (SPRY) reported a $215.4M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has ARS Pharmaceuticals, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, ARS Pharmaceuticals, Inc. (SPRY) net income went from -$32.9M in fiscal year 2020 to -$171.3M in fiscal year 2025.
What was ARS Pharmaceuticals, Inc.'s net income in the most recent quarter?
ARS Pharmaceuticals, Inc. (SPRY) reported -$62.3M in net income in Q2 2026. This represents a decrease of 38.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what ARS Pharmaceuticals, Inc. (SPRY) reported on that line in every period on record.